Early-stage Access Strategy & Implementation: EASI

In our view, optimal development of innovative healthcare technologies requires market access to be taken into consideration at an early stage. With EASI, we look at disease-specific unmet medical needs, cost of treatment, natural history of disease, epidemiology and other factors that have an impact on the value of a treatment for patients and healthcare organizations. We use this information to outline product-specific market access strategies and leverage our capabilities to coordinate the implementation of early-stage activities.